A general explainer from Health on getting weight loss results from Ozempic, Wegovy and Zepbound, with a focus on using them correctly.
Recap by typeshit. Post by Health on X.
BMO's Evan Seigerman expects US share losses to weigh on Ozempic sales, while the 25% CagriSema figure comes from a post-hoc subgroup, not the full trial's 22.7%.
Beauty companies are reportedly exploring products aimed at facial changes linked to rapid weight loss on GLP-1 drugs.
A search page for retatrutide news with no specific story attached, so there is little new beyond recent coverage.
2:06:48
A live Q&A stream from DOWNSIZED taking viewer questions about GLP-1 medications, including Zepbound, Wegovy and Foundayo.
A short post from the endocrinologist pushing back on headlines tying the eye condition to GLP-1 drugs, urging people to look at the data.
Researchers using genetic data from over 200,000 men say those predisposed to androgenetic alopecia face added risk. Lead author Lynn Petukhova suggests screening someday.
Loading…